Technical Analysis for PYC - Physiomics Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Historical PYC trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Fell Below 200 DMA | Bearish | -1.43% | |
| Upper Bollinger Band Walk | Strength | -1.43% | |
| 50 DMA Resistance | Bearish | -3.50% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.50% | |
| 200 DMA Support | Bullish | -3.50% | |
| Upper Bollinger Band Touch | Strength | -3.50% | |
| 50 DMA Resistance | Bearish | -3.50% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.50% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 1.5x Volume Pace | 1 day ago |
| Fell Below 10 DMA | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Down 2% | 1 day ago |
| Down 1% | 1 day ago |
Get this analysis on your stocks daily!
Physiomics Plc Description
Physiomics Plc is engaged in the provision of outsourced systems and computational biology services to pharmaceutical companies. The Company is focused on the development of Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials; Cardiac tox prediction service, to predict unwanted toxic side effects of drug candidates in the drug discovery process, and Drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. Its services include Target Validation, Mechanism of Action Studies, Lead Selection, Clinical Pharmacokinetic/Pharmacodynamics (PK/PD), EASYAP/Cardiac Toxicity Service, Virtual Tumour Preclinical and Virtual Tumour Clinical. It offers a services and technology for predicting cardiac toxicity. It also focuses on offering offer Model Based Drug Development (MBDD) services, which include Population PKPD analysis of clinical data and Back-translational analysis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Target Research Pharmaceutical Clinic Analysis Clinical Trial Biology Pharmaceutical Industry Drug Discovery Drug Development Omics Health Sciences Translation Validation Dynamics Pharmaceutical Companies Pharmaceutical Sciences Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.25 |
| 52 Week Low | 2.31 |
| Average Volume | 549,254 |
| 200-Day Moving Average | 7.07 |
| 50-Day Moving Average | 7.22 |
| 20-Day Moving Average | 6.73 |
| 10-Day Moving Average | 6.91 |
| Average True Range | 0.41 |
| ADX | 24.89 |
| +DI | 23.56 |
| -DI | 11.50 |
| Chandelier Exit (Long, 3 ATRs ) | 6.27 |
| Chandelier Exit (Short, 3 ATRs ) | 7.37 |
| Upper Bollinger Band | 7.22 |
| Lower Bollinger Band | 6.24 |
| Percent B (%b) | 0.68 |
| BandWidth | 14.53 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.09 |
| MACD Histogram | 0.0785 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.20 | ||||
| Resistance 3 (R3) | 7.20 | 7.10 | 7.15 | ||
| Resistance 2 (R2) | 7.10 | 7.02 | 7.10 | 7.13 | |
| Resistance 1 (R1) | 7.00 | 6.98 | 7.05 | 7.00 | 7.12 |
| Pivot Point | 6.90 | 6.90 | 6.93 | 6.90 | 6.90 |
| Support 1 (S1) | 6.80 | 6.82 | 6.85 | 6.80 | 6.68 |
| Support 2 (S2) | 6.70 | 6.78 | 6.70 | 6.67 | |
| Support 3 (S3) | 6.60 | 6.70 | 6.65 | ||
| Support 4 (S4) | 6.60 |
